Prothrombin complex concentrate (Octaplex®) in patients requiring immediate reversal of oral anticoagulation
Authors:
- Andreas Meier-HellmannAMAndreas Meier-Hellmann
- Johann MotschJMJohann Motsch
- Mazen EliasMEMazen Elias
- Friedrich W. KurstenFKFriedrich W. Kursten
- Carl-Erik DempfleCDCarl-Erik Dempfle
- 1 January 2007
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 121 (1) , 9-16
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Vermeidung von Notfallsituationen bei gerinnungshemmender Therapie mit Vitamin-K-AntagonistenDie Innere Medizin, 2005
- The Norwegian plasma fractionation project––a 12 year clinical and economic success storyTransfusion and Apheresis Science, 2003
- The management of coumarin‐induced over‐anticoagulationBritish Journal of Haematology, 2001
- Manufacturing of a Prothrombin Complex Concentrate Aiming at Low ThrombogenicityThrombosis Research, 2000
- Virus Safety of Prothrombin Complex Concentrates and Factor IX ConcentratesThrombosis Research, 1999
- Management of warfarin (coumarin) overdoseBlood Reviews, 1998
- Thromboembolic Complications Associated with the Use of Prothrombin Complex and Factor IX ConcentratesThrombosis and Haemostasis, 1998
- Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT)The Lancet, 1996
- Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart ValvesNew England Journal of Medicine, 1995
- Bleeding complications in oral anticoagulant therapy. An analysis of risk factorsArchives of internal medicine (1960), 1993